Angiopoietin 1 |
ANGPT1 |
3.01 |
Breast cancer 1, early onset |
BRCA1 |
−3.18 |
Cyclin-dependent kinase 2 |
CDK2 |
2.46 |
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
CDKN1A |
7.41 |
Interferon α1 |
IFNα1 |
5.66 |
Interferon β1, fibroblast |
IFNβ1 |
6.87 |
Integrin α1 |
ITGα1 |
5.66 |
Integrin α2 |
ITGα2 |
18.25 |
Integrin β1 |
ITGβ1 |
11.71 |
Integrin β3 |
ITGβ3 |
59.30 |
Integrin β5 |
ITGβ5 |
5.82 |
Matrix metallopeptidase 1 |
MMP1 |
59.30 |
Matrix metallopeptidase 9 |
MMP9 |
55.33 |
Metastasis associated 1 |
MTA1 |
2.19 |
Metastasis associated 1 family, member 2 |
MTA2 |
1.82 |
Metastasis suppressor 1 |
MTSS1 |
5.58 |
Platelet-derived growth factor β polypeptide |
PDGFB |
9.51 |
Plasminogen activator, urokinase |
PLAU |
2.64 |
Plasminogen activator, urokinase receptor |
PLAUR |
8.00 |
Serpin peptidase inhibitor, clade E (plasminogen activator inhibitor-1) |
SERPINE1 |
168.90 |
Transforming growth factor β1 |
TGFβ1 |
5.54 |
Transforming growth factor β receptor 1 |
TGF-βR1 |
3.46 |
Thrombospondin 1 |
THBS1 |
9.25 |
Tumor necrosis factor receptor superfamily, member 10b |
TNFRSF10B |
2.16 |
Tumor necrosis factor receptor superfamily, member 25 |
TNFRSF25 |
3.53 |
Vascular endothelial growth factor A |
VEGFA |
23.26 |